The effect of spinal cord-injury level on the outcome of neurogenic bladder treatment using OnabotulinumtoxinA

The effect of spinal cord-injury level on the outcome of neurogenic bladder treatment using OnabotulinumtoxinA

Aim: The aim was to report the effectiveness and safety OnabotulinumtoxinA (Botox, Allergan, Inc., Irvine, CA, USA) intradetrusor injections in spinal cord-injured (SCI) patients with refractory neurogenic detrusor overactivity. And to assess the result based on SCI level. Materials and Methods: We...

Full description

Bibliographic Details
Main Authors: Waleed Al Taweel, Khalil Mohammed Alzyoud
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:Urology Annals
Subjects:
Neurogenic bladder
OnabotulinumtoxinA
overactive
spinal cord-injury
Online Access:http://www.urologyannals.com/article.asp?issn=0974-7796;year=2015;volume=7;issue=3;spage=320;epage=324;aulast=Al

Internet

http://www.urologyannals.com/article.asp?issn=0974-7796;year=2015;volume=7;issue=3;spage=320;epage=324;aulast=Al

Similar Items